Overview

Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections

Status:
Terminated
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
This study will treat hemodialysis patients who have a central catheter that is thought to be infected with a specific bacteria (Gram positive bacteria).
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Cefazolin
Linezolid
Vancomycin